The development of the treatment for heart failure using non-pulsatile Left ventricle assist device

The development of the treatment for heart failure using non-pulsatile Left ventricle assist device - The development of the treatment for heart failure using non-pulsatile Left ventricle assist device

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003665

Enrollment

Registered

2010-05-25

Start date

2009-12-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-staged dilated cardiomyopathy and ischemic cardiomyopathy who receive Left ventricle assist devise

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (a) Severe heart failure patient whosesymptoms is NYHA 4 after treatment of maximum medication and surgical procedure. (b) Applicable age is over 15 years old and under 75 years old (c) Informed concent

Exclusion criteria

Exclusion criteria: (a) Malingant cancer (b)Pregnancy (c)Patients who is unsuitable for this clinical protocol (by doctor's decision)

Design outcomes

Primary

Measure	Time frame
We will analyse the survival curve and complication rate after the reimplantation of implantable left ventricle assist devise.	—

Countries

Japan

Outcome results